Operating Margin

Curia announces major upgrades to its UK sterile manufacturing and US biologics platforms, a strategic move to accelerate drug development timelines.

Chinese lifestyle group Atour surpasses growth targets with a 35% revenue jump, fueled by hotel expansion and a booming retail business.

Showcasing its Cogynt.ai platform, Cogility plans to shift security from reactive detection to proactive, behavior-based prevention of insider risks.

The iconic NYC burger chain is coming to Calgary, but can its premium menu and local sourcing win over a city fiercely loyal to its own burger joints?

Mark Reinbold takes the CEO role at CSC ServiceWorks, signaling a major strategic shift toward tech-driven, service-led models for the laundry giant.

Jim Teske, the executive behind VRC's national expansion, is leaving. What does his departure mean for the company's aggressive acquisition strategy?

As MediciNova execs meet investors at the ROTH Conference, all eyes are on pivotal updates for its ALS, MS, and NAFLD drug candidates.

After a failed reverse stock split, shipping firm OceanPal faces delisting. Can its ambitious AI subsidiary, SovereignAI, save it from the exchange?

Following a landmark year of profitability, Carvana aims to make its stock more accessible to employees and investors with its first-ever stock split.

The German biotech firm secured its Nasdaq listing, but a near-total investor redemption leaves its cancer-drug pipeline with less than $1M in trust funds.

BRC Group Holdings announced a major debt reduction, but a history of late filings, shareholder dilution, and high-risk bets cast a shadow on its recovery.

As AI strains data centers, Adtran unveils breakthrough low-power optics and quantum-safe networks at OFC 2026 to build a sustainable AI future.

A global industrial giant's 10-14% surcharge reveals the direct line from Mideast conflict to higher costs for your local hospital and restaurant.

Wiz, SailPoint, and Vanta are adopting Sweep’s agentic AI to manage and audit legacy Salesforce environments, signaling a major shift in enterprise governance.

Industry pioneer Lee Leichter joins EdgeOne Medical, a strategic move to master the complex, high-stakes world of combination product regulation.

Psyence BioMed is building a pharmaceutical powerhouse by controlling its supply chain, a strategic move that could redefine the future of psychedelic medicine.

A new report shows Munich and Hamburg are outpacing rivals in attracting investment, leveraging online credibility as a powerful new tool on the global stage.

Calgary-based Rubellite Energy posts a stellar 2025, with record output and lower costs, now pivoting to advanced oil recovery for long-term growth.

As automation demand soars, ATS Corp. will meet investors to outline its strategy for navigating market shifts and capitalizing on life sciences growth.

Amid mixed results, Kimball Electronics heads to key investor conferences with a new growth story fueled by medical tech and a raised financial outlook.